United States · FDA National Drug Code directory
Lisinopril and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-969_2815b0ef-9835-4b49-b98d-8519e7005dc1
- Product NDC
- 69097-969
- Form
- TABLET
- Composition / generic term
- Lisinopril and Hydrochlorothiazide Tablets
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191226
- Source listing expiry
- 20261231
Source-listed ingredients
- LISINOPRIL — 20 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (69097-969-05) · 69097-969-05
- 100 TABLET in 1 BOTTLE (69097-969-07) · 69097-969-07
- 500 TABLET in 1 BOTTLE (69097-969-12) · 69097-969-12
- 1000 TABLET in 1 BOTTLE (69097-969-15) · 69097-969-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →